Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-24 · accession 0001209191-22-039654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-28 | 2022-06-24+ | RLAY | Bergstrom Donald A | Pres, R, D | S - Sale+OE | $20.03 | -8,999 | 92.5K | -9% | -$180.3K |
| D | 2022-06-28 | 2022-06-24 | RLAY | Bergstrom Donald A | Pres, R, D | M - OptEx | $4.12 | +8,000 | 100.5K | +9% | +$33.0K |
| D | 2022-06-28 | 2022-06-24 | RLAY | Bergstrom Donald A | Pres, R, D | M - OptEx | $0.00 | -8,000 | 178.5K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | S | D | 999 | $20.31 | 91,494 | D | — | — | (F3) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of RSUs on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F4) Includes 84,953 shares underlying RSUs. |
| 2 | Common | Common Stock | 2022-06-24 | M | A | 8,000 | $4.12 | 100,493 | D | — | — | (F2) Includes 87,141 shares underlying restricted stock units ("RSUs"). |
| 3 | Common | Common Stock | 2022-06-24 | S | D | 8,000 | $20.00 | 92,493 | D | — | — | (F2) Includes 87,141 shares underlying restricted stock units ("RSUs"). |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-06-24 | M | D | 8,000 | $0.00 | 178,456 | D | $4.12 · — to 2028-04-09 | 8,000 Common Stock | (F5) Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |